By health condition
By demographic
Each summary is provided by the external research team. The views expressed may not reflect those of the NIHR BioResource.
We’ve also created a few study collections:
Studies 334-342 of 422
Determining risk for extravascular haemolysis in paroxysmal nocturnal haemoglobinuria patients treated with eculizumab
Speciality areaHaematology, Infection
Study typeSamples and data
Researcher typeAcademic
Research leadProfessor Claire Harris
Complement activation to predict Sars-CoV-2 outcome
Speciality areaInfection, COVID
Research leadDr Richard Unwin
Healthcare Worker Case Control COVID-19 Questionnaire
Study typeParticipant re-contact
Research leadDan Cooper
Healthcare Worker COVID follow up
Defining the therapeutic potential of CD25 (IL2-R) blockade as a novel treatment for genetically stratified Crohn’s disease patients
Speciality areaGastroenterology
Research leadProfessor Graham Lord
HICC: Humoral Immune Correlates for COVID19: Defining protective Ab responses and critical readouts for Clinical Trials of Vaccines and Therapeutics
Research leadDr Helen Baxendale
Monogenic immune deficiency diseases
Speciality areaGenomics and Rare Diseases
Study typeData only
Research leadManish Butte
Testing biotx.ai's AI for wide data in Rare Diseases
Researcher typeCommercial
Research leadMarco Schmidt
Can Covid-19 outcome be revealed by single cell analysis?
Research leadPaul Lyons